Handwriting boosts brain connectivity and learning

As digital devices progressively replace pen and paper, taking notes by hand is becoming increasingly uncommon in schools and universities.

MSD’s Welireg secures FDA approval for renal cell carcinoma – Pharmaceutical Technology

Share this article The FDA based its decision for the second approval of the drug on results from MSD’s LITESPARK-005 trial (NCT04195750). Image credit: Shutterstock/Magic

December 15, 2023

Largest study of BRCA1 and BRCA2 carriers refines cancer risk estimates in Asian population

A team of clinician-scientists and scientists from the University of Nottingham (Malaysia campus), National Cancer Centre Singapore (NCCS), Cancer Research Malaysia, Nanyang Technological University, Singapore

April 26, 2024

Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonists

ANAHEIM, Calif. — Insurance coverage and out-of-pocket costs for GLP-1 receptor agonists pose serious barriers to patients prescribed these drugs for type 2 diabetes and

December 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.